C-RWZBPonce de Leon Health
drug-free longevity, anti-aging, healthspan
consumer products
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-RWZB
C-RWZBC-RWZBdrug-free longevity, anti-aging, healthspan
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Ponce de Leon Health drug-free longevity, anti-aging, healthspan
Ponce de Leon Health is dedicated to researching and commercializing drug-free solutions scientifically shown to extend longevity and improve healthspan. The company seeks to reverse the effects of biological aging and moderate aging as a cause of degenerative disease. It was founded in 2014 by Tom Weldon, who entered into a sponsored research agreement with the Buck Institute for Research on Aging to develop a safe, affordable, science-backed, non-drug product.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Ponce de Leon Health — Far from goals · Bottom quartile. Derived deterministically from 3 extracted project(s). Most-advanced status: exploratory. Band: far. Modifiers: +5 depth (2 programs at exploratory).…
Source: Deterministic